000			01371 a2200397 4500
005			20250513185220.0
264		0	_c19990825
008			199908s 0 0 eng d
022			_a0009-3157
024	7		_a10.1159/000048465 _2doi
040			_aNLM _beng _cNLM
100	1		_ade Pauw, B E
245	0	0	_aThe challenge of invasive fungal infection. _h[electronic resource]
260			_bChemotherapy _cJun 1999
300			_a1-14 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAIDS-Related Opportunistic Infections _xdrug therapy
650	0	4	_aAmphotericin B _xtherapeutic use
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aAspergillosis _xdrug therapy
650	0	4	_aCandidiasis _xdrug therapy
650	0	4	_aCryptococcosis _xdrug therapy
650	0	4	_aDeoxycholic Acid _xtherapeutic use
650	0	4	_aDrug Combinations
650	0	4	_aFluconazole _xtherapeutic use
650	0	4	_aFlucytosine _xtherapeutic use
650	0	4	_aFungemia _xdrug therapy
650	0	4	_aHistoplasmosis _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aMycoses _xdrug therapy
650	0	4	_aZygomycosis _xdrug therapy
700	1		_aMeunier, F
773	0		_tChemotherapy _gvol. 45 Suppl 1 _gp. 1-14
856	4	0	_uhttps://doi.org/10.1159/000048465 _zAvailable from publisher's website
999			_c10352296 _d10352296